Combination therapy of metformin and p-coumaric acid mitigates metabolic dysfunction associated with obesity and nonalcoholic fatty liver disease in high-fat diet obese C57BL/6 mice
Golnaz Goodarzi, Sadra Samavarchi Tehrani, Ghodratollah Panahi, Arash Bahramzadeh, Reza Meshkani
Topics & Concepts
Nonalcoholic fatty liver diseaseInternal medicineEndocrinologySteatosisCombination therapyMedicineMetforminAdipocyteTriglycerideFatty liverAdipose tissueCholesterolDiabetes mellitusDiseaseAdipose Tissue and MetabolismDiet and metabolism studiesAdipokines, Inflammation, and Metabolic Diseases